Convergence Investment Partners »

Catalyst Pharmaceutical Partners shares owned by Convergence Investment Partners

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Convergence Investment Partners from 13F filings

Historical chart of Convergence Investment Partners investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Convergence Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Convergence Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $714k 36k 19.70
2025-06-30 $1.2M 55k 21.70
2022-12-31 $148k 7.9k 18.60

More positions owned by Convergence Investment Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
International Business Machines (IBM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Bank of New York Mellon Corporation (BK)
Abbvie (ABBV)
At&t (T)
Alphabet Cap Stk Cl C (GOOG)
Altria (MO)
Applovin Corp Com Cl A (APP)
JPMorgan Chase & Co. (JPM)

View all positions for Convergence Investment Partners

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners